{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T01:46:32Z","timestamp":1778982392974,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,8]],"date-time":"2017-08-08T00:00:00Z","timestamp":1502150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,8,8]],"date-time":"2017-08-08T00:00:00Z","timestamp":1502150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pathological cardiac hypertrophy, a dynamic remodeling process, is a major risk factor for heart failure. Although a number of key regulators and related genes have been identified, how the transcription factors (TFs) dynamically regulate the associated genes and control the morphological and electrophysiological changes during the hypertrophic process are still largely unknown. In this study, we obtained the time-course transcriptomes at five time points in four weeks from male murine hearts subjected to transverse aorta banding surgery. From a series of computational analyses, we identified three major co-expression modules of TF genes that may regulate the gene expression changes during the development of cardiac hypertrophy in mice. After pressure overload, the TF genes in Module 1 were up-regulated before the occurrence of significant morphological changes and one week later were down-regulated gradually, while those in Modules 2 and 3 took over the regulation as the heart size increased. Our analyses revealed that the TF genes up-regulated at the early stages likely initiated the cascading regulation and most of the well-known cardiac miRNAs were up-regulated at later stages for suppression. In addition, the constructed time-dependent regulatory network reveals some TFs including <jats:italic>Egr2<\/jats:italic> as new candidate key regulators of cardiovascular-associated (CV) genes.<\/jats:p>","DOI":"10.1038\/s41598-017-07981-4","type":"journal-article","created":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T09:57:08Z","timestamp":1501667828000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Three TF Co-expression Modules Regulate Pressure-Overload Cardiac Hypertrophy in Male Mice"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6618-862X","authenticated-orcid":false,"given":"Yao-Ming","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Ting","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Wang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Hsiung","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur Chun-Chieh","family":"Shih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Chang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,8]]},"reference":[{"key":"7981_CR1","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1161\/01.CIR.0000120390.68287.BB","volume":"109","author":"N Frey","year":"2004","unstructured":"Frey, N., Katus, H. A., Olson, E. N. & Hill, J. A. Hypertrophy of the heart: a new therapeutic target? Circulation \n                           109, 1580\u20131589, doi:10.1161\/01.CIR.0000120390.68287.BB (2004).","journal-title":"Circulation"},{"key":"7981_CR2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.pharmthera.2010.04.005","volume":"128","author":"BC Bernardo","year":"2010","unstructured":"Bernardo, B. C., Weeks, K. L., Pretorius, L. & McMullen, J. R. Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies. Pharmacol Ther \n                           128, 191\u2013227, doi:10.1016\/j.pharmthera.2010.04.005 (2010).","journal-title":"Pharmacol Ther"},{"key":"7981_CR3","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nrm3619","volume":"14","author":"M Xin","year":"2013","unstructured":"Xin, M., Olson, E. N. & Bassel-Duby, R. Mending broken hearts: cardiac development as a basis for adult heart regeneration and repair. Nat Rev Mol Cell Biol \n                           14, 529\u2013541, doi:10.1038\/nrm3619 (2013).","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7981_CR4","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1161\/01.RES.0000072977.86706.23","volume":"92","author":"H Akazawa","year":"2003","unstructured":"Akazawa, H. & Komuro, I. Roles of cardiac transcription factors in cardiac hypertrophy. Circ Res \n                           92, 1079\u20131088, doi:10.1161\/01.RES.0000072977.86706.23 (2003).","journal-title":"Circ Res"},{"key":"7981_CR5","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1161\/01.RES.0000046452.67724.B8","volume":"91","author":"I Manabe","year":"2002","unstructured":"Manabe, I., Shindo, T. & Nagai, R. Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy. Circ Res \n                           91, 1103\u20131113 (2002).","journal-title":"Circ Res"},{"key":"7981_CR6","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.cell.2012.03.001","volume":"148","author":"S Kathiresan","year":"2012","unstructured":"Kathiresan, S. & Srivastava, D. Genetics of human cardiovascular disease. Cell \n                           148, 1242\u20131257, doi:10.1016\/j.cell.2012.03.001 (2012).","journal-title":"Cell"},{"key":"7981_CR7","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1161\/CIRCRESAHA.111.247437","volume":"110","author":"M Abdellatif","year":"2012","unstructured":"Abdellatif, M. Differential expression of microRNAs in different disease states. Circ Res \n                           110, 638\u2013650, doi:10.1161\/CIRCRESAHA.111.247437 (2012).","journal-title":"Circ Res"},{"key":"7981_CR8","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nrm1983","volume":"7","author":"J Heineke","year":"2006","unstructured":"Heineke, J. & Molkentin, J. D. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol \n                           7, 589\u2013600, doi:10.1038\/nrm1983 (2006).","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7981_CR9","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/nature09783","volume":"469","author":"EM Small","year":"2011","unstructured":"Small, E. M. & Olson, E. N. Pervasive roles of microRNAs in cardiovascular biology. Nature \n                           469, 336\u2013342, doi:10.1038\/nature09783 (2011).","journal-title":"Nature"},{"key":"7981_CR10","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1056\/NEJMra072139","volume":"358","author":"JA Hill","year":"2008","unstructured":"Hill, J. A. & Olson, E. N. Cardiac plasticity. N Engl J Med \n                           358, 1370\u20131380, doi:10.1056\/NEJMra072139 (2008).","journal-title":"N Engl J Med"},{"key":"7981_CR11","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/35025190","volume":"407","author":"D Srivastava","year":"2000","unstructured":"Srivastava, D. & Olson, E. N. A genetic blueprint for cardiac development. Nature \n                           407, 221\u2013226, doi:10.1038\/35025190 (2000).","journal-title":"Nature"},{"key":"7981_CR12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.semcdb.2006.11.012","volume":"18","author":"T Oka","year":"2007","unstructured":"Oka, T., Xu, J. & Molkentin, J. D. Re-employment of developmental transcription factors in adult heart disease. Semin Cell Dev Biol \n                           18, 117\u2013131, doi:10.1016\/j.semcdb.2006.11.012 (2007).","journal-title":"Semin Cell Dev Biol"},{"key":"7981_CR13","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1161\/CIRCRESAHA.108.193102","volume":"104","author":"S Rane","year":"2009","unstructured":"Rane, S. et al. Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ Res \n                           104, 879\u2013886, doi:10.1161\/CIRCRESAHA.108.193102 (2009).","journal-title":"Circ Res"},{"key":"7981_CR14","doi-asserted-by":"publisher","first-page":"6745","DOI":"10.1073\/pnas.100127897","volume":"97","author":"CJ Friddle","year":"2000","unstructured":"Friddle, C. J., Koga, T., Rubin, E. M. & Bristow, J. Expression profiling reveals distinct sets of genes altered during induction and regression of cardiac hypertrophy. Proc Natl Acad Sci USA \n                           97, 6745\u20136750, doi:10.1073\/pnas.100127897 (2000).","journal-title":"Proc Natl Acad Sci USA"},{"key":"7981_CR15","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1161\/CIRCGENETICS.108.806935","volume":"2","author":"SP Sheehy","year":"2009","unstructured":"Sheehy, S. P., Huang, S. & Parker, K. K. Time-warped comparison of gene expression in adaptive and maladaptive cardiac hypertrophy. Circ Cardiovasc Genet \n                           2, 116\u2013124, doi:10.1161\/CIRCGENETICS.108.806935 (2009).","journal-title":"Circ Cardiovasc Genet"},{"key":"7981_CR16","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.ygeno.2006.04.012","volume":"88","author":"BJ van den Bosch","year":"2006","unstructured":"van den Bosch, B. J. et al. Early and transient gene expression changes in pressure overload-induced cardiac hypertrophy in mice. Genomics \n                           88, 480\u2013488, doi:10.1016\/j.ygeno.2006.04.012 (2006).","journal-title":"Genomics"},{"key":"7981_CR17","first-page":"161","volume":"3","author":"FZ Meerson","year":"1961","unstructured":"Meerson, F. Z. On the mechanism of compensatory hyperfunction and insufficiency of the heart. Cor Vasa \n                           3, 161\u2013177 (1961).","journal-title":"Cor Vasa"},{"key":"7981_CR18","doi-asserted-by":"publisher","first-page":"H1261","DOI":"10.1152\/ajpheart.00108.2003","volume":"285","author":"P Hu","year":"2003","unstructured":"Hu, P. et al. Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload. Am J Physiol Heart Circ Physiol \n                           285, H1261\u20131269, doi:10.1152\/ajpheart.00108.2003 (2003).","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"7981_CR19","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1161\/CIRCRESAHA.108.184051","volume":"104","author":"CS Chiang","year":"2009","unstructured":"Chiang, C. S. et al. The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice. Circ Res \n                           104, 522\u2013530, doi:10.1161\/CIRCRESAHA.108.184051 (2009).","journal-title":"Circ Res"},{"key":"7981_CR20","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1161\/01.RES.0000109415.17511.18","volume":"94","author":"BJ Wilkins","year":"2004","unstructured":"Wilkins, B. J. et al. Calcineurin\/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ Res \n                           94, 110\u2013118, doi:10.1161\/01.RES.0000109415.17511.18 (2004).","journal-title":"Circ Res"},{"key":"7981_CR21","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1093\/cvr\/cvt190","volume":"100","author":"SC Hsu","year":"2013","unstructured":"Hsu, S. C., Chang, Y. T. & Chen, C. C. Early growth response 1 is an early signal inducing Cav3.2 T-type calcium channels during cardiac hypertrophy. Cardiovasc Res \n                           100, 222\u2013230, doi:10.1093\/cvr\/cvt190 (2013).","journal-title":"Cardiovasc Res"},{"key":"7981_CR22","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1157\/13087900","volume":"59","author":"JE Carreno","year":"2006","unstructured":"Carreno, J. E., Apablaza, F., Ocaranza, M. P. & Jalil, J. E. [Cardiac hypertrophy: molecular and cellular events]. Rev Esp Cardiol \n                           59, 473\u2013486 (2006).","journal-title":"Rev Esp Cardiol"},{"key":"7981_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1161\/CIRCRESAHA.117.305349","volume":"117","author":"T Kamo","year":"2015","unstructured":"Kamo, T., Akazawa, H. & Komuro, I. Cardiac nonmyocytes in the hub of cardiac hypertrophy. Circ Res \n                           117, 89\u201398, doi:10.1161\/CIRCRESAHA.117.305349 (2015).","journal-title":"Circ Res"},{"key":"7981_CR24","doi-asserted-by":"publisher","first-page":"A3","DOI":"10.1136\/heartjnl-2015-308734.7","volume":"101","author":"CS McCarroll","year":"2015","unstructured":"McCarroll, C. S. et al. Runx1 deficiency protects against adverse cardiac remodelling following myocardial infarction. Heart \n                           101, A3, doi:10.1136\/heartjnl-2015-308734.7 (2015).","journal-title":"Heart"},{"key":"7981_CR25","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.1073\/pnas.0307875101","volume":"101","author":"MT Tetzlaff","year":"2004","unstructured":"Tetzlaff, M. T. et al. Defective cardiovascular development and elevated cyclin E and Notch proteins in mice lacking the Fbw7 F-box protein. Proc Natl Acad Sci USA \n                           101, 3338\u20133345, doi:10.1073\/pnas.0307875101 (2004).","journal-title":"Proc Natl Acad Sci USA"},{"key":"7981_CR26","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1097\/01.CCM.0000256723.37586.A2","volume":"35","author":"X Zhu","year":"2007","unstructured":"Zhu, X. et al. Toll-like receptor 2 activation by bacterial peptidoglycan-associated lipoprotein activates cardiomyocyte inflammation and contractile dysfunction. Crit Care Med \n                           35, 886\u2013892, doi:10.1097\/01.CCM.0000256723.37586.A2 (2007).","journal-title":"Crit Care Med"},{"key":"7981_CR27","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1152\/japplphysiol.90955.2008","volume":"105","author":"KA Huey","year":"2008","unstructured":"Huey, K. A. & Meador, B. M. Contribution of IL-6 to the Hsp72, Hsp25, and alphaB-crystallin [corrected] responses to inflammation and exercise training in mouse skeletal and cardiac muscle. J Appl Physiol (1985) \n                           105, 1830\u20131836, doi:10.1152\/japplphysiol.90955.2008 (2008).","journal-title":"J Appl Physiol (1985)"},{"key":"7981_CR28","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ydbio.2007.02.002","volume":"305","author":"J Lincoln","year":"2007","unstructured":"Lincoln, J., Kist, R., Scherer, G. & Yutzey, K. E. Sox9 is required for precursor cell expansion and extracellular matrix organization during mouse heart valve development. Dev Biol \n                           305, 120\u2013132, doi:10.1016\/j.ydbio.2007.02.002 (2007).","journal-title":"Dev Biol"},{"key":"7981_CR29","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1097\/FJC.0b013e31829b82e6","volume":"62","author":"ZH Zhang","year":"2013","unstructured":"Zhang, Z. H. et al. MicroRNA-26 was decreased in rat cardiac hypertrophy model and may be a promising therapeutic target. J Cardiovasc Pharmacol \n                           62, 312\u2013319, doi:10.1097\/FJC.0b013e31829b82e6 (2013).","journal-title":"J Cardiovasc Pharmacol"},{"key":"7981_CR30","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.bbagrm.2014.07.009","volume":"1839","author":"F Hernandez-Torres","year":"2014","unstructured":"Hernandez-Torres, F., Aranega, A. E. & Franco, D. Identification of regulatory elements directing miR-23a-miR-27a-miR-24-2 transcriptional regulation in response to muscle hypertrophic stimuli. Biochim Biophys Acta \n                           1839, 885\u2013897, doi:10.1016\/j.bbagrm.2014.07.009 (2014).","journal-title":"Biochim Biophys Acta"},{"key":"7981_CR31","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1161\/CIRCRESAHA.110.228437","volume":"108","author":"Y Yang","year":"2011","unstructured":"Yang, Y., Ago, T., Zhai, P., Abdellatif, M. & Sadoshima, J. Thioredoxin 1 negatively regulates angiotensin II-induced cardiac hypertrophy through upregulation of miR-98\/let-7. Circ Res \n                           108, 305\u2013313, doi:10.1161\/CIRCRESAHA.110.228437 (2011).","journal-title":"Circ Res"},{"key":"7981_CR32","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1146\/annurev.physiol.59.1.551","volume":"59","author":"J Sadoshima","year":"1997","unstructured":"Sadoshima, J. & Izumo, S. The cellular and molecular response of cardiac myocytes to mechanical stress. Annu Rev Physiol \n                           59, 551\u2013571, doi:10.1146\/annurev.physiol.59.1.551 (1997).","journal-title":"Annu Rev Physiol"},{"key":"7981_CR33","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1146\/annurev.ph.55.030193.000453","volume":"55","author":"KR Chien","year":"1993","unstructured":"Chien, K. R. et al. Transcriptional regulation during cardiac growth and development. Annu Rev Physiol \n                           55, 77\u201395, doi:10.1146\/annurev.ph.55.030193.000453 (1993).","journal-title":"Annu Rev Physiol"},{"key":"7981_CR34","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/416334a","volume":"416","author":"HB Xin","year":"2002","unstructured":"Xin, H. B. et al. Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy. Nature \n                           416, 334\u2013338, doi:10.1038\/416334a (2002).","journal-title":"Nature"},{"key":"7981_CR35","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/nm1272","volume":"11","author":"M Buitrago","year":"2005","unstructured":"Buitrago, M. et al. The transcriptional repressor Nab1 is a specific regulator of pathological cardiac hypertrophy. Nat Med \n                           11, 837\u2013844, doi:10.1038\/nm1272 (2005).","journal-title":"Nat Med"},{"key":"7981_CR36","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.stem.2014.11.004","volume":"16","author":"R Kramann","year":"2015","unstructured":"Kramann, R. et al. Perivascular Gli1\u2009+\u2009progenitors are key contributors to injury-induced organ fibrosis. Cell Stem Cell \n                           16, 51\u201366, doi:10.1016\/j.stem.2014.11.004 (2015).","journal-title":"Cell Stem Cell"},{"key":"7981_CR37","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.yjmcc.2010.08.023","volume":"49","author":"F Vitelli","year":"2010","unstructured":"Vitelli, F., Lania, G., Huynh, T. & Baldini, A. Partial rescue of the Tbx1 mutant heart phenotype by Fgf8: genetic evidence of impaired tissue response to Fgf8. J Mol Cell Cardiol \n                           49, 836\u2013840, doi:10.1016\/j.yjmcc.2010.08.023 (2010).","journal-title":"J Mol Cell Cardiol"},{"key":"7981_CR38","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1161\/01.RES.0000257780.60484.6a","volume":"100","author":"M Choi","year":"2007","unstructured":"Choi, M., Stottmann, R. W., Yang, Y. P., Meyers, E. N. & Klingensmith, J. The bone morphogenetic protein antagonist noggin regulates mammalian cardiac morphogenesis. Circ Res \n                           100, 220\u2013228, doi:10.1161\/01.RES.0000257780.60484.6a (2007).","journal-title":"Circ Res"},{"key":"7981_CR39","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/bioinformatics\/19.2.185","volume":"19","author":"BM Bolstad","year":"2003","unstructured":"Bolstad, B. M., Irizarry, R. A., Astrand, M. & Speed, T. P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics \n                           19, 185\u2013193 (2003).","journal-title":"Bioinformatics"},{"key":"7981_CR40","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ipl.2013.01.016","volume":"113","author":"JM Schmidt","year":"2013","unstructured":"Schmidt, J. M. A simple test on 2-vertex- and 2-edge-connectivity. Information Processing Letters \n                           113, 241\u2013244, doi:10.1016\/j.ipl.2013.01.016 (2013).","journal-title":"Information Processing Letters"},{"key":"7981_CR41","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1101\/gr.096305.109","volume":"20","author":"J Ernst","year":"2010","unstructured":"Ernst, J., Plasterer, H. L., Simon, I. & Bar-Joseph, Z. Integrating multiple evidence sources to predict transcription factor binding in the human genome. Genome Res \n                           20, 526\u2013536, doi:10.1101\/gr.096305.109 (2010).","journal-title":"Genome Res"},{"key":"7981_CR42","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nature11245","volume":"489","author":"MB Gerstein","year":"2012","unstructured":"Gerstein, M. B. et al. Architecture of the human regulatory network derived from ENCODE data. Nature \n                           489, 91\u2013100, doi:10.1038\/nature11245 (2012).","journal-title":"Nature"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-07981-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-07981-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-07981-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T08:13:12Z","timestamp":1671783192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-07981-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,8]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["7981"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-07981-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,8]]},"assertion":[{"value":"20 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"7560"}}